Clincosm LogoSign in Get a demo

recurrent primary peritoneal carcinoma

Showing 26 - 50 of 54
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Female Reproductive System Tumor, Recurrent Cervical Carcinoma, Recurrent Endometrial Carcinoma Trial in Houston

Recruiting
  • Malignant Female Reproductive System Neoplasm
  • +24 more
  • Quality-of-Life Assessment
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 6, 2022

Recurrent Endometrial Serous Adenocarcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Aurora

Active, not recruiting
  • Recurrent Endometrial Serous Adenocarcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Aurora, Colorado
    University of Colorado Hospital
May 24, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +6 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 17, 2022

Malignant Ovarian Epithelial Tumor, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma Trial in

Recruiting
  • Malignant Ovarian Epithelial Tumor
  • +9 more
  • Akt/ERK Inhibitor ONC201
  • +2 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
May 10, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Seattle

Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 10, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Buffalo

Active, not recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Aldesleukin
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 3, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

Completed
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +44 more
Jan 10, 2022

Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Los Angeles

Recruiting
  • Recurrent Endometrial Carcinoma
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 28, 2021

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Bronx, New York

Completed
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Bronx, New York
  • +2 more
Oct 18, 2021

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
Has Results
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +17 more
  • Phoenix, Arizona
  • +162 more
Sep 28, 2021

Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Cystadenocarcinoma Trial in Jacksonville,

Completed
Has Results
  • Ovarian Endometrioid Adenocarcinoma
  • +8 more
  • Jacksonville, Florida
  • +1 more
Sep 28, 2020

High Grade Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Primary Peritoneal High Grade Serous

Withdrawn
  • High Grade Fallopian Tube Serous Adenocarcinoma
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +19 more
  • Hartford, Connecticut
  • +13 more
Aug 8, 2019

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

Completed
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Mobile, Alabama
  • +141 more
Jul 22, 2019

Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma Trial in United

Completed
  • Ovarian Clear Cell Cystadenocarcinoma
  • +7 more
  • Bevacizumab
  • +4 more
  • Aurora, Colorado
  • +12 more
Jul 19, 2019

Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma Trial in United

Completed
  • Ovarian Clear Cell Cystadenocarcinoma
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +6 more
Mar 8, 2019

Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,

Completed
Has Results
  • Adult Hepatocellular Carcinoma
  • +44 more
  • Scottsdale, Arizona
  • +60 more
Jan 24, 2019

Basal-Like Breast Carcinoma, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier Trial in United States (Laboratory Biomarker

Completed
  • Basal-Like Breast Carcinoma
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +6 more
Jun 28, 2018

Recurrent Ovarian Epithelial Cancer, Recurrent Fallopian Tube Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Duarte

Completed
  • Recurrent Ovarian Epithelial Cancer
  • +2 more
  • modified vaccinia virus ankara vaccine expressing p53
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Apr 26, 2018

Estrogen Receptor Negative, HER2/Neu Negative, Male Breast Carcinoma Trial in Bronx, New York (Laboratory Biomarker Analysis,

Completed
  • Estrogen Receptor Negative
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Bronx, New York
  • +5 more
Dec 21, 2017

Adult Solid Tumor, Peritoneal Carcinomatosis, Recurrent Fallopian Tube Carcinoma Trial in Baltimore, Toronto (other, radiation,

Completed
  • Adult Solid Neoplasm
  • +4 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Baltimore, Maryland
  • +2 more
Nov 20, 2017

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

Completed
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Rilotumumab
  • Burbank, California
  • +27 more
Aug 8, 2017

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Canada, United

Completed
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +5 more
  • Gamma-Secretase Inhibitor RO4929097
  • Laboratory Biomarker Analysis
  • Beverly Hills, California
  • +11 more
Apr 17, 2017

Collecting Tumor Samples From Patients With Gynecological Tumors

Completed
  • Borderline Ovarian Clear Cell Tumor
  • +85 more
  • Laboratory Biomarker Analysis
  • Fayetteville, Arkansas
  • +186 more
Oct 26, 2016

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Columbus

Completed
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Wild-type Reovirus
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 5, 2016